Skip to main content
Log in

The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Nutritional status assessment is essential in cancer patients because a poor nutritional status has been associated with poor outcomes; however, the impact of rapid turnover proteins (RTPs), such as prealbumin, transferrin, and retinol-binding protein, on the outcomes of hepatocellular carcinoma (HCC) has not been well-investigated. We therefore examined the prognostic significance of RTPs in patients with HCC after curative resection.

Methods

This study included 150 patients who underwent elective hepatic resection for HCC between January 2011 and December 2018. The prealbumin, transferrin, and retinol-binding protein levels were classified into two groups (high vs. low); the RTP score (0–3) was calculated as the sum of each RTP measurement (high = 0; low = 1). We retrospectively investigated the relationship between the RTP score and disease-free and overall survival.

Results

Multivariate analysis showed that a high RTP score (P = 0.022), presence of sarcopenia (P = 0.001), and stage III or higher (P = 0.005) were independent predictors of disease-free survival, while a high RTP score (P < 0.001), presence of sarcopenia (P = 0.017), and stage III or higher (P = 0.012) were independent predictors of overall survival. In patients with high RTP scores, positive hepatitis B and C viral infection, high indocyanine green (ICG) at 15 min (ICGR15), Child–Pugh grade B, poorly differentiated carcinoma, and postoperative ascites were more common than in patients with low RTP scores.

Conclusion

The preoperative RTP score may be a prognostic factor in patients with hepatocellular carcinoma after hepatic resection, suggesting an important role of RTP in the assessment of nutritional status in cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

    Article  Google Scholar 

  2. Yang HJ, Guo Z, Yang YT, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol. 2016;22:5088–95.

    Article  CAS  Google Scholar 

  3. Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012;29:2005–9.

    Article  CAS  Google Scholar 

  4. Yang J, Bao Y, Chen W, Duan Y, Sun D. Nomogram based on systemic immune inflammation index and prognostic nutrition index predicts recurrence of hepatocellular carcinoma after surgery. Front Oncol. 2020;10:551668.

    Article  Google Scholar 

  5. Shen Y, Wang H, Li W, Chen J. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA. J Clin Lab Anal. 2019;33:e22999.

    PubMed  PubMed Central  Google Scholar 

  6. Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM, Xiang BD. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep. 2018;8:2535.

    Article  Google Scholar 

  7. He C, Zhang Y, Cai Z, Lin X. The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy. Cancer Manag Res. 2019;11:1391–400.

    Article  CAS  Google Scholar 

  8. Pan J, Chen S, Tian G, Jiang T. Preoperative albumin-bilirubin grade with prognostic nutritional index predicts the outcome of patients with early-stage hepatocellular carcinoma after percutaneous radiofrequency ablation. Front Med (Lausanne). 2020;7:584871.

    Article  Google Scholar 

  9. Watanabe T, Shibata M, Nishiyama H, et al. Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer. Oncol Lett. 2014;7:373–7.

    Article  Google Scholar 

  10. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.

    Article  CAS  Google Scholar 

  11. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12:351–5.

    Article  Google Scholar 

  12. Ueno S, Tanabe G, Nuruki K, et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res. 2002;24:395–403.

    Article  Google Scholar 

  13. Nagai S, Mangus RS, Kubal CA, et al. Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival. Clin Transplant. 2015;29:1156–63.

    Article  CAS  Google Scholar 

  14. Haruki K, Shiba H, Shirai Y, et al. The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection. World J Surg. 2016;40:2254–60.

    Article  Google Scholar 

  15. Masuda T, Shirabe K, Ikegami T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.

    Article  Google Scholar 

  16. Toyoda H, Lai PB, O’Beirne J, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114:744–50.

    Article  CAS  Google Scholar 

  17. Inoue Y, Nezu R, Matsuda H, Takagi Y, Okada A. Rapid turnover proteins as a prognostic indicator in cancer patients. Surg Today. 1995;25:498–506.

    Article  CAS  Google Scholar 

  18. Cavarocchi NC, Au FC, Dalal FR, Friel K, Mildenberg B. Rapid turnover proteins as nutritional indicators. World J Surg. 1986;10:468–73.

    Article  CAS  Google Scholar 

  19. Hu X, Huang W, Wang F, et al. Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: a case-control study. Medicine (Baltimore). 2020;99:e21254.

    Article  CAS  Google Scholar 

  20. Norden AGW, Burling KA, Zeni L, Unwin RJ. A new estimate of the glomerular sieving coefficient for retinol-binding protein 4 suggests it is not freely filtered. Kidney Int Rep. 2019;4:1017–8.

    Article  Google Scholar 

  21. Dong ZR, Zou J, Sun D, et al. Preoperative albumin-bilirubin score for postoperative solitary hepatocellular carcinoma within the milan criteria and child-pugh a cirrhosis. J Cancer. 2017;8:3862–7.

    Article  Google Scholar 

  22. Liao YY, Teng CL, Peng NF, et al. Serum prealbumin is negatively associated with survival in hepatocellular carcinoma patients after hepatic resection. J Cancer. 2019;10:3006–11.

    Article  CAS  Google Scholar 

  23. Cavallin F, Scarpa M, Cagol M, Alfieri R, Castoro C. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 2013;37:2005.

    Article  Google Scholar 

  24. Yuan S, Carter P, Vithayathil M, et al. Iron status and cancer risk in UK biobank: a two-sample mendelian randomization study. Nutrients. 2020;12:526.

    Article  CAS  Google Scholar 

  25. Shimura T, Shibata M, Inoue T, et al. Prognostic impact of serum transthyretin in patients with non-small cell lung cancer. Mol Clin Oncol. 2019;10:597–604.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Harimoto N, Yoshizumi T, Shimokawa M, et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res. 2016;46:1247–55.

    Article  Google Scholar 

  27. Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.

    Article  CAS  Google Scholar 

  28. McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr. 2003;77:764–70.

    Article  CAS  Google Scholar 

  29. Giger U, Buchler M, Farhadi J, et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol. 2007;14:2798–806.

    Article  Google Scholar 

  30. Mocellin MC, Fernandes R, Chagas TR, Trindade E. A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer. Clin Nutr. 2018;37:840–50.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by JSPS KAKENHI grants JP21K08718 (to TI) and JP21K08805 (to KH) and by a research grant from the Uehara Memorial Foundation (to TI). The authors would like to thank Editage (www.editage.com) for English-language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichiro Haruki MD, PhD.

Ethics declarations

Disclosure

Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Takeshi Gocho, Tomohiko Taniai, Ryoga Hamura, and Toru Ikegami declare they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanagaki, M., Haruki, K., Yasuda, J. et al. The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection. Ann Surg Oncol 28, 8130–8139 (2021). https://doi.org/10.1245/s10434-021-10704-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10704-9

Keywords

Navigation